BGH revises takeover bid to Virtus Health (ASX:VRT)

Company News

by Lauren Evans

Reproductive technology and IVF specialist Virtus Health (ASX:VRT) has received a revised takeover bid from BGH Capital. 

In a non-binding proposal, BGH improved its takeover offer to $7.65 a share, less any dividends declared by Virtus. It had previously offered $7.10 a share.

It also said it would vote its 19.99 per cent stake in the business against the rival bid from CapVest.

“BGH will vote all Virtus shares that it owns or controls at the relevant time against any CapVest proposal to acquire Virtus by way of scheme of arrangement, and BGH will not accept into any takeover offer from CapVest with respect to all Virtus shares that it owns or controls at the relevant time,” said BGH.

Shares in Virtus Health (ASX:VRT) are trading 3.5 per cent higher at $7.50. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.